005500.KS
Samjin Pharmaceuticals Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 18,820.00
+0.86%Margins
Gross margin
45.6%
EBITDA margin
6.2%
EBIT margin
6.7%
Net margin
7.5%
FCF margin
8.3%
7.8%
Return on equity
4.9%
Return on assets
4.9%
Return on invested capital
0.67x
Asset turnover
KRW 33.8B
Cash from operations
KRW 1.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026